Pages that link to "Q40341163"
Jump to navigation
Jump to search
The following pages link to Peroxisome-proliferator-activated receptor alpha agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1. (Q40341163):
Displaying 39 items.
- Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease? (Q26824893) (← links)
- Therapeutic Potential of Peroxisome Proliferator-Activated Receptors in Chronic Inflammation and Colorectal Cancer (Q27687166) (← links)
- Tazarotene-induced gene 1 inhibits prostaglandin E2-stimulated HCT116 colon cancer cell growth (Q34086015) (← links)
- Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway. (Q34483561) (← links)
- 20-Hydroxyeicosatetraenoic acid inhibits ATP-induced COX-2 expression via peroxisome proliferator activator receptor-α in vascular smooth muscle cells. (Q35036189) (← links)
- Crosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progression (Q35539784) (← links)
- Simultaneous inhibition of EGFR/VEGFR and cyclooxygenase-2 targets stemness-related pathways in colorectal cancer cells (Q35673201) (← links)
- Role of leukotrienes in N-(3,5-dichlorophenyl)succinimide (NDPS) and NDPS metabolite nephrotoxicity in male Fischer 344 rats (Q36142142) (← links)
- The role of peroxisome proliferator-activated receptors in colorectal cancer (Q36248494) (← links)
- Activation of peroxisome proliferator-activated receptor α (PPARα) suppresses hypoxia-inducible factor-1α (HIF-1α) signaling in cancer cells (Q36318813) (← links)
- 1,1-Bis(3'-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice (Q36393316) (← links)
- PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition. (Q36458927) (← links)
- Anticancer Properties of PPARalpha-Effects on Cellular Metabolism and Inflammation (Q36675898) (← links)
- Peroxisome proliferator-activated receptors and progression of colorectal cancer (Q36710291) (← links)
- Silencing of AP-4 inhibits proliferation, induces cell cycle arrest and promotes apoptosis in human lung cancer cells (Q36954636) (← links)
- PPARs Mediate Lipid Signaling in Inflammation and Cancer (Q37021709) (← links)
- Peroxisome proliferator-activated receptor alpha acts as a mediator of endoplasmic reticulum stress-induced hepatocyte apoptosis in acute liver failure. (Q37120406) (← links)
- Multiple Interactions between Peroxisome Proliferators-Activated Receptors and the Ubiquitin-Proteasome System and Implications for Cancer Pathogenesis (Q37190455) (← links)
- Role of peroxisome proliferator-activated receptor alpha in the control of cyclooxygenase 2 and vascular endothelial growth factor: involvement in tumor growth. (Q37231752) (← links)
- The Role of PPARs in the Endothelium: Implications for Cancer Therapy (Q37337997) (← links)
- Minireview: Won't get fooled again: the nonmetabolic roles of peroxisome proliferator-activated receptors (PPARs) in the heart. (Q37656896) (← links)
- PPARα, a predictor of patient survival in glioma, inhibits cell growth through the E2F1/miR-19a feedback loop (Q37708993) (← links)
- MicroRNA-33a promotes cell proliferation and inhibits apoptosis by targeting PPARα in human hepatocellular carcinoma (Q38701714) (← links)
- Soluble epoxide hydrolase limits mechanical hyperalgesia during inflammation (Q38736745) (← links)
- Ionomycin induces prostaglandin E2 formation in murine osteoblastic MC3T3-E1 cells via mechanisms independent of its ionophoric nature (Q38779290) (← links)
- PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation. (Q39145017) (← links)
- Involvement of PPARs in Cell Proliferation and Apoptosis in Human Colon Cancer Specimens and in Normal and Cancer Cell Lines. (Q41983546) (← links)
- PPAR Could Contribute to the Pathogenesis of Hepatocellular Carcinoma (Q42125206) (← links)
- PPARG Epigenetic Deregulation and Its Role in Colorectal Tumorigenesis. (Q42250957) (← links)
- Roles of peroxisome proliferator-activated receptor-alpha and -gamma in the development of non-small cell lung cancer (Q43191818) (← links)
- Prostacyclin-induced peroxisome proliferator-activated receptor-alpha translocation attenuates NF-kappaB and TNF-alpha activation after renal ischemia-reperfusion injury. (Q45916574) (← links)
- Drug repositioning for gynecologic tumors: a new therapeutic strategy for cancer. (Q52962540) (← links)
- High expression of AP-4 predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy. (Q54288204) (← links)
- The overexpression of AP-4 as a prognostic indicator for gastric carcinoma. (Q54386815) (← links)
- C/VDdb: A multi-omics expression profiling database for a knowledge-driven approach in cardiovascular disease (CVD) (Q59136824) (← links)
- UDN glycoprotein inhibits activator protein-1 and matrix metalloproteinase-9 via blocking of oxygen radicals in HT-29 cells (Q80203138) (← links)
- Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis (Q89766936) (← links)
- Energy Restriction and Colorectal Cancer: A Call for Additional Research (Q92446005) (← links)
- Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors (Q92709736) (← links)